PCSK9 and breast carcinoma: Considering the key role of PCSK9 on lipid metabolism (hyperlipidemic factor) and immune response (destruction of MHC-I), confirmation of increased PCSK9 levels with breast cancer severity in a larger cohort of patients is indicated.